← All drugs Report issue

mono-dga-rfb4

mAbexperimentalADC

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

CD22BINDING AGENT
CD22 binding agent
- B-cell receptor CD22 (CD22) ↗
CD22INHIBITOR
CD22 inhibitor
- B-cell receptor CD22 (CD22) ↗

Chemistry & pharmacology

Chirality: Single Stereoisomer
Inorganic: No
Polymer: No
Multi-specific: No
Payload: Ricin A chain

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL2109354 ↗

Also known as

mono-dga-rfb4